1. Home
  2. CNSP vs CETX Comparison

CNSP vs CETX Comparison

Compare CNSP & CETX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNSP
  • CETX
  • Stock Information
  • Founded
  • CNSP 2017
  • CETX 1998
  • Country
  • CNSP United States
  • CETX United States
  • Employees
  • CNSP N/A
  • CETX N/A
  • Industry
  • CNSP Biotechnology: Pharmaceutical Preparations
  • CETX EDP Services
  • Sector
  • CNSP Health Care
  • CETX Technology
  • Exchange
  • CNSP Nasdaq
  • CETX Nasdaq
  • Market Cap
  • CNSP 4.0M
  • CETX 3.5M
  • IPO Year
  • CNSP 2019
  • CETX 1998
  • Fundamental
  • Price
  • CNSP $6.51
  • CETX $3.55
  • Analyst Decision
  • CNSP Strong Buy
  • CETX
  • Analyst Count
  • CNSP 1
  • CETX 0
  • Target Price
  • CNSP $20.00
  • CETX N/A
  • AVG Volume (30 Days)
  • CNSP 18.0K
  • CETX 74.3K
  • Earning Date
  • CNSP 11-17-2025
  • CETX 12-29-2025
  • Dividend Yield
  • CNSP N/A
  • CETX N/A
  • EPS Growth
  • CNSP N/A
  • CETX N/A
  • EPS
  • CNSP N/A
  • CETX N/A
  • Revenue
  • CNSP N/A
  • CETX $76,095,551.00
  • Revenue This Year
  • CNSP N/A
  • CETX $19.77
  • Revenue Next Year
  • CNSP N/A
  • CETX $15.00
  • P/E Ratio
  • CNSP N/A
  • CETX N/A
  • Revenue Growth
  • CNSP N/A
  • CETX 16.50
  • 52 Week Low
  • CNSP $4.93
  • CETX $3.07
  • 52 Week High
  • CNSP $114.00
  • CETX $133.88
  • Technical
  • Relative Strength Index (RSI)
  • CNSP 41.69
  • CETX 40.98
  • Support Level
  • CNSP $6.04
  • CETX $3.07
  • Resistance Level
  • CNSP $6.90
  • CETX $5.07
  • Average True Range (ATR)
  • CNSP 0.57
  • CETX 0.42
  • MACD
  • CNSP -0.05
  • CETX -0.24
  • Stochastic Oscillator
  • CNSP 24.29
  • CETX 24.87

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

About CETX Cemtrex Inc.

Cemtrex Inc is a multi-industry technology company. It has expanded in a range of sectors, including smart technologies, virtual and augmented realities, industrial solutions, and intelligent security system. The company's operating segment includes, Security segment, Industrial Services segment and the corporate segment. The security segment provides end to end security to all industrial, corporate and governmental security via owned subsidiary Vicon. Whereas AIS part Industrial Service Segment is expertise services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. It generates maximum revenue from the Industrial Service Segment. It geographically operates in USA, UK and India, with maximum of revenue from USA.

Share on Social Networks: